36th Annual Meeting

Molecular Biology of Cancer

Date Monday, October 22 - Wednesday, October 24, 2007
Location Gl. Avernæs Conference Centre, Helnæsvej, Ebberup, Fyn
Organizers

Program

Monday, 22 October, 2007:

12.00 – 13.00

Arrival and Registration.

14.00 – 17.00

SESSION I: Epigenetics in cancer.

 

Organizer: Anders H. Lund, BRIC, Copenhagen University.

 

Anja Groth, Dept. Of Chromatin Dynamics, Institut Curie, France: Epigenetic gene regulation.

 

Karl Agger, Biotech Research and Innovation Centre, Copenhagen University, Denmark: Histone demethylation and cancer.

 

Maarten van Lohuizen, Division of Molecular Genetics, Netherlands Cancer Institute, Amsterdam, The Netherlands: Polycomb silencers control cell fate, development and cancer.

 

François Fuks, Free University of Brussels, Faculty of Medicine, Laboratory of Molecular Virology, Brussels, Belgium: DNA methylation directed by EZH2.

 

Anders H. Lund, BRIC, Copenhagen University. Polycomb complexes and silencing mechanisms.

20.00 – 21.30

EMBO LECTURE: Nancy Hynes, Friedrich Miescher Institute for Biomedical Research, Basel, Switzerland: ERBB receptors and cancer: the complexity of targeted inhibitors.

Tuesday, 23 October, 2007:

09.00 – 12.00

SESSION II: Cellular signaling in cancer.

 

Organizer: Tuula Kallunki, Danish Cancer Society, Copenhagen.

 

Mark Philips, NYU Cancer Institute, Smilow Research, NYU School of Medicine, New York, USA: Trafficking of small GTPases in relation to cancer.

 

Richard Marais, Institute of Cancer Research, Cancer Research UK Centre for Cell and Molecular Biology, London, UK: B-Raf mutations in melanoma.

 

Bo Van Deurs, Institute of Medical Anatomy, Copenhagen University, Denmark: Endocytic downregulation of ErbB receptors.

 

Tuula Kallunki, Department of Apoptosis, Institute of Biological Cancer Research, Danish Cancer Society, Copenhagen, Denmark: ErbB2 signaling pathways in the regulation of cysteine cathepsins.

 

Simon Bekker-Jensen, Centre for Genotoxic stress, Danish Cancer Society, Copenhagen, Denmark: DNA damage induces cell cycle arrest via ATR og Chk1 signaling.

13.00 – 15.00

SESSION III: Young Researchers on Molecular Cancer Biology.

 

Organizer: Steen Gammeltoft, Glostrup Hospital, Glostrup.

 

Niels Mailand, Centre for Genotoxic stress, Danish Cancer Society, Copenhagen, Denmark: The RNF8 ubiquitin ligase is a novel signalling component in the DNA damage response.

 

Maria Høyer-Hansen, Apoptosis Department, Institute of Cancer Biology, Danish Cancer Society, Copenhagen, Denmark: The putative anti-cancer drug, EB1089, induces calcium and CaMKK-β dependent autophagy in breast cancer cells

 

Speakers are selected among submitted abstracts.

15.00 – 18.00

SESSION IV: Exhibition, Poster Session and Refreshments

Wednesday, 24 October, 2007:

09.00 – 12.00

SESSION V: Molecular medicine in cancer management.

 

Organizer: Peter Hokland, Department of Hematology, Aarhus University Hospital, Aarhus, Denmark.

 

Manfred Dietel, Institute of Pathology, Charité, University Hospital Berlin Personalized medicine and development of targeted therapies: The upcoming challenge for diagnostic molecular pathology. 

 

Lars Dyrskøt, Department of Clinical Biochemistry, Skejby Hospital, University of Aarhus, Denmark: Recent developments in molecular profiling of bladder cancer. 

 

Bo Sandahl Sørensen, Department of Clinical-Biochemistry, NBG, AS, Aarhus University Hospital, Aarhus, Denmark: Growth factors, chemotherapy and cancer.

 

Jesper Stentoft, Department of Hematology, Aarhus University Hospital, Aarhus, Denmark: Modern therapy of chronic myeloid leukemia: Response evaluation and analysis of failure

 

Peter Hokland, Department of Hematology, Aarhus University Hospital, Aarhus, Denmark: Minimal residual leukemia – a model for translational assays in cancer management.

13.00

Departure.